1. Home
  2. UBX vs ARBB Comparison

UBX vs ARBB Comparison

Compare UBX & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • ARBB
  • Stock Information
  • Founded
  • UBX 2009
  • ARBB 1997
  • Country
  • UBX United States
  • ARBB Singapore
  • Employees
  • UBX N/A
  • ARBB N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • ARBB EDP Services
  • Sector
  • UBX Health Care
  • ARBB Technology
  • Exchange
  • UBX Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • UBX 16.5M
  • ARBB 14.9M
  • IPO Year
  • UBX 2018
  • ARBB 2023
  • Fundamental
  • Price
  • UBX $1.73
  • ARBB $0.52
  • Analyst Decision
  • UBX Strong Buy
  • ARBB
  • Analyst Count
  • UBX 2
  • ARBB 0
  • Target Price
  • UBX $7.00
  • ARBB N/A
  • AVG Volume (30 Days)
  • UBX 303.9K
  • ARBB 158.4K
  • Earning Date
  • UBX 11-04-2024
  • ARBB 11-22-2024
  • Dividend Yield
  • UBX N/A
  • ARBB N/A
  • EPS Growth
  • UBX N/A
  • ARBB N/A
  • EPS
  • UBX N/A
  • ARBB N/A
  • Revenue
  • UBX N/A
  • ARBB $12,334,474.00
  • Revenue This Year
  • UBX N/A
  • ARBB N/A
  • Revenue Next Year
  • UBX $33.62
  • ARBB N/A
  • P/E Ratio
  • UBX N/A
  • ARBB N/A
  • Revenue Growth
  • UBX N/A
  • ARBB N/A
  • 52 Week Low
  • UBX $0.94
  • ARBB $0.22
  • 52 Week High
  • UBX $2.02
  • ARBB $4.55
  • Technical
  • Relative Strength Index (RSI)
  • UBX 63.32
  • ARBB 49.89
  • Support Level
  • UBX $1.56
  • ARBB $0.52
  • Resistance Level
  • UBX $1.85
  • ARBB $0.75
  • Average True Range (ATR)
  • UBX 0.22
  • ARBB 0.08
  • MACD
  • UBX 0.05
  • ARBB 0.00
  • Stochastic Oscillator
  • UBX 75.96
  • ARBB 34.15

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

Share on Social Networks: